Publications by authors named "Gary D Novack"

Claim this Profile
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular Hypertension.
Lee Shettle, Jay Mulaney, Robert D Williams, Jennifer Beck, Jeanette A Stewart, Gary D Novack

J Ocul Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pipeline: Pharmacotherapy of dry eye disease in vertebrates.
Gary D Novack, Sara M Thomasy, Brian Leonard

Ocul Surf· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pipeline: Patient, physician and developer view of drugs vs. devices.
Gary D Novack

Ocul Surf· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VVN461 Solution in Patients with Acute Noninfectious Anterior Uveitis.
Liu Yang, Jing Zhang, Xiao-Yan Li, Guanglin Shen, Caroline Lu, Gary D Novack

Ophthalmology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation From Ophthalmic Research to Ophthalmic Products.
Gary D Novack, William J Brock, Audrey R Schupp

Am J Ophthalmol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tribute to Gary N. Foulks, M.D. (1944-2025) and his contributions to the ocular surface.
Michael H Goldstein, Deepinder Dhaliwal, Ed Isbey, Stephen Pflugfelder, Mark J Mannis, Gary D Novack

Ocul Surf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pipeline: Therapeutics - Two views of off-label use.
Gary D Novack

Ocul Surf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases.
Gary D Novack

Am J Ophthalmol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pipeline: US FDA efficacy requirements for treatment of ocular surface disease: Drugs vs. medical devices.
R Lee Kramm, Gary D Novack

Ocul Surf· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-Masked, Dose-Response, Vehicle-Controlled Study of VVN461 Ophthalmic Solution in Postoperative Ocular Inflammation.
James H Peace, Kevin Y Jong, Jason Bacharach, Xiao-Yan Li, Wang Shen, Gary D Novack

Ophthalmol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Diagnostic Error in Ocular Surface Disease: The Role of Anchoring and Ambiguous Diagnostic Terminology.
Todd P Margolis, Anat Galor, Gary D Novack

JAMA Ophthalmol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pipeline: Pricing for drugs treating dry eye disease.
S Osman Hussain, Gary D Novack

Ocul Surf· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pipeline: Wiley Chambers, MD, FDA Ophthalmology regulator.
Gary D Novack

Ocul Surf· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eyes on New Product Development.
Gary D Novack

J Ocul Pharmacol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis